International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 394 | 2019 |
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of … BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ... Gut 67 (11), 1920-1941, 2018 | 377 | 2018 |
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications JR Allegretti, BH Mullish, C Kelly, M Fischer The Lancet 394 (10196), 420-431, 2019 | 302 | 2019 |
Effects of fecal microbiota transplantation with oral capsules in obese patients JR Allegretti, Z Kassam, BH Mullish, A Chiang, M Carrellas, J Hurtado, ... Clinical Gastroenterology and Hepatology 18 (4), 855-863. e2, 2020 | 239 | 2020 |
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection BH Mullish, JAK McDonald, A Pechlivanis, JR Allegretti, D Kao, GF Barker, ... Gut 68 (10), 1791-1800, 2019 | 225 | 2019 |
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance J Glen, L Floros, C Day, R Pryke Bmj 354, 2016 | 204 | 2016 |
Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial JR Allegretti, Z Kassam, M Carrellas, BH Mullish, JR Marchesi, ... Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019 | 199 | 2019 |
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis SMD Baunwall, MM Lee, MK Eriksen, BH Mullish, JR Marchesi, ... EClinicalMedicine 29, 2020 | 179 | 2020 |
Clostridium difficile infection and antibiotic-associated diarrhoea BH Mullish, HRT Williams Clinical Medicine 18 (3), 237-241, 2018 | 174 | 2018 |
Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota JAK McDonald, BH Mullish, A Pechlivanis, Z Liu, J Brignardello, D Kao, ... Gastroenterology 155 (5), 1495-1507. e15, 2018 | 168 | 2018 |
Optimized sample handling strategy for metabolic profiling of human feces J Gratton, J Phetcharaburanin, BH Mullish, HRT Williams, M Thursz, ... Analytical chemistry 88 (9), 4661-4668, 2016 | 165 | 2016 |
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ... The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020 | 161 | 2020 |
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 146 | 2020 |
Depression and the use of antidepressants in patients with chronic liver disease or liver transplantation BH Mullish, MS Kabir, MR Thursz, A Dhar Alimentary pharmacology & therapeutics 40 (8), 880-892, 2014 | 123 | 2014 |
High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease R Forlano, BH Mullish, N Giannakeas, JB Maurice, N Angkathunyakul, ... Clinical Gastroenterology and Hepatology 18 (9), 2081-2090. e9, 2020 | 113 | 2020 |
Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease BH Mullish, A Pechlivanis, GF Barker, MR Thursz, JR Marchesi, ... Methods 149, 49-58, 2018 | 102 | 2018 |
Antibiotic therapy and outcome from immune-checkpoint inhibitors DJ Pinato, D Gramenitskaya, DM Altmann, RJ Boyton, BH Mullish, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 96 | 2019 |
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms P Fessas, LA Possamai, J Clark, E Daniels, C Gudd, BH Mullish, ... Immunology 159 (2), 167-177, 2020 | 95 | 2020 |
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial B Routy, JG Lenehan, WH Miller Jr, R Jamal, M Messaoudene, ... Nature medicine 29 (8), 2121-2132, 2023 | 88 | 2023 |
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being DR Michael, AA Jack, G Masetti, TS Davies, KE Loxley, J Kerry-Smith, ... Scientific reports 10 (1), 4183, 2020 | 87 | 2020 |